PAVM
PAVmed Inc
-33.63%
$0.57 - $0.38
Feb 7th 2023 - Mar 21st 2023
Jan, 24, 2023
I am actually happy they decided to move on from t... See more
Jan, 19, 2023
All we need is one product to be successful and we... See more
AUPH
Aurinia Pharmaceuticals Inc
3.07%
$8.48 - $8.74
Feb 8th 2023 - Mar 22nd 2023
Mar, 22, 2023
For a one product company, we sure have a lot of p... See more
Mar, 19, 2023
Should be very easy to beat EOY guidance for product revenue.
Jan, 24, 2023
I am actually happy they decided to move on from their other products such as CarpNext and NextBlow.
Jan, 19, 2023
All we need is one product to be successful and we’ve got potentially two.
Jan, 18, 2023
This company has great products and great promise,
Dec, 28, 2022
We have many products in la la land with unicorns and everlasting gobstoppers !
Dec, 16, 2022
EXAS would get a wonderful product in ESO Guard which compliments its Colo Guard product perfectly.
Dec, 13, 2022
$PAVM industry seems to like the product though!
Mar, 20, 2023
Terasana is probably a very good product,
Mar, 20, 2023
Clearly the products have efficacy.
Mar, 17, 2023
This brand is growing extremely naturally and when mom’s approve of a product they tend to spread like wildfire and we’re seeing that.
Mar, 16, 2023
Just disaster after disaster, it's unbelievable when the products are just so incredible.
Feb, 23, 2023
They do have more than enough for now .. and more R&D is coming, plus the steady product sales revs.
Feb, 21, 2023
This shelf has been restocked which means 4U by Tia is selling pretty good (better than any other consumer product Amyris ever developed) and the company did not run out of cash.
Feb, 8, 2023
I should add that the product seems fine, fast and free shipping, well packaged, fair price… why does this not appear to be selling?
Feb, 3, 2023
Buy the product, try it and spread the word.
Feb, 3, 2023
$AMRS These were full of our curlyhair product, amazing.
Feb, 3, 2023
Also news on their latest line of products sound optimistic. BULLISH
Mar, 22, 2023
For a one product company, we sure have a lot of people feeding off of it; think management, the board, the fantastic sales team.
Mar, 19, 2023
Should be very easy to beat EOY guidance for product revenue.
Feb, 14, 2023
The product is good.
Jan, 26, 2023
First product to market usually secures the top spot for a long time, and Benlysta has delivered well for GSK.
Nov, 21, 2022
$AUPH Another 1 trick pony ZM getting killed and they have a better product.
Nov, 11, 2022
Real product,
Oct, 20, 2022
3 other approved products, all growing revenue.
Oct, 13, 2022
$AUPH looking at RLMD, we can be glad we have an approved product here that works well for its patients.